2 Day Medical Device Studies Training Course: Regulatory Requirements and Adverse Event Reporting (January 18-19, 2023) - ResearchAndMarkets.com
30 Nov 2022
DUBLIN--(BUSINESS WIRE)--The "Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Training Course" conference has been added to ResearchAndMarkets.com's offering.
'Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Training Course'
This seminar provides an essential overview of medical device clinical evaluations, clinical investigations and PMCF studies with particular emphasis on the adverse event reporting requirements during these studies.
The course will concentrate mostly on the new Medical Device Regulations (MDR) with some references to the existing Medical Device Directives.
It will provide a good introduction to medical device clinical studies and serve as an update for those with experience who need to keep abreast of the regulatory changes and the methods of handling adverse events during the study period.
It also covers the new requirements regarding periodic safety update reports (PSURs) and the summary of safety and clinical performance.
Who Should Attend:
Regulatory affairs specialists
Quality assurance specialists
Clinical research associates
Junior clinical research associates
Professionals involved in reporting adverse events during pre- and post-market clinical studies
Key Topics Covered:
Clinical evaluation - An overview
What is a clinical evaluation?
How do you conduct a clinical evaluation?
The regulatory requirements pertaining to clinical evaluation
Clinical investigations - An overview
What is a clinical investigation?
When are clinical investigations needed?
The regulatory requirements
PMS and PMCF
What is PMS?
What is PMCF?
When are PMCF studies necessary?
Quiz on clinical evaluation, clinical investigation and PMCF
New requirements of the MDR
Summary of safety and clinical performance
Periodic safety update report (PSUR)
The competent authority and the Notified Body
What is their role in the above processes?
What are the responsibilities of the manufacturer?
What to communicate and when
Workshop on the new requirements of the MDR
Vigilance reporting
What is vigilance?
The requirements for vigilance reporting during medical device studies
How to define and classify adverse events
Definitions
Types of events
Determining categories
Vigilance workshop
The regulatory requirements for monitoring and reporting adverse events during regulatory and PMCF studies
MEDDEV guidance document
ISO 14155 harmonised standard
Responsibilities
Templates
The MDR - clinical elements
Focus on changes in the clinical arena
Chapter 6: clinical evaluation and investigation
Annex 14: clinical evaluation and post-market clinical follow-up
Speakers
Janette Benaddi
Director of Clinical & Consulting Europe
NAMSA
Janette Benaddi is a business mentor, international speaker/trainer and consultant to the medical device industry. Janette has over 25 years' experience of managing pre and post market clinical studies in both devices and pharmaceuticals. Janette has worked with several multinational organizations in various clinical, regulatory and marketing roles. She has extensive experience of conducting clinical studies with medical device products as well as regulatory expertise for CE marking of devices. Specifically she has been involved in writing and reviewing hundreds of Clinical evaluation reports for the medical device industry, she ahs also provided training to Notified bodies in this subject.
Janette qualified as a registered nurse in 1984, she has a BSc in Management studies, a Diploma in Company Direction, and a Diploma in Management studies, holds a teaching certificate and is a Chartered Scientist and Chartered Director. Janette sits on several committees in the device community and industry and has been an instrumental advocate of improving and advancing medical device research in the UK. Janette has published several articles relating to medical device regulation and clinical studies.
For more information about this conference visit https://www.researchandmarkets.com/r/c5ljr1
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.